A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder

Clinical trial NCT07204314 · RECRUITING

Trial details

NCT number: NCT07204314
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2025-10-01
Primary completion: 2029-09-30
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.